B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologicsRenaud Felten, Jacques‐Eric Gottenberg, M. Ardizzone et al.|Annals of the Rheumatic Diseases|2021Cited by 20
Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritidesRenaud Felten, Jean-Hugues Salmon, M. Geoffroy et al.|Joint Bone Spine|2022Cited by 1
Ce que nous apprennent nos HDJ sur la réponse vaccinale anti-SARS-CoV-2 différente sous traitements ciblant les lymphocytes B et T par rapport aux traitements anti-cytokiniquesRenaud Felten, Jean‐Hugues Salmon, M. Geoffroy et al.|Revue du Rhumatisme|2021Cited by 0